NSE · MEDICAMEQ
Medicamen Biotech Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,986
of 5,084 stocks
→ 01W
Peak #1,986 · 21 Sep 2026
A microcap name in Healthcare, Medicamen Biotech Limited is growing revenue at a solid clip, has a subdued return on equity, and commands a premium earnings multiple.
Market Cap
436.72 Cr
P/E Ratio
44.60
P/B Ratio
1.58
ROE
3.56%
ROCE
5.45%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 47.90 Cr | 60.65 Cr | 46.91 Cr | 47.17 Cr |
| Net Profit | 1.85 Cr | 4.45 Cr | 1.63 Cr | 2.11 Cr |
| EPS | 1.36 | 3.28 | 1.21 | 1.56 |
| Operating Profit | 3.40 Cr | 5.44 Cr | 3.08 Cr | 3.67 Cr |
Shareholding pattern
Promoter
40.46%
Public
59.54%
Mutual fund holdings
₹0.00
Cr total
1
Schemes
1
Fund Houses
₹0.00 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.00 Cr (100.0%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 19 Sep 2025 | Dividend | Dividend - Re 1 Per Share |
| 19 Sep 2024 | Dividend | Annual General Meeting/Dividend - Re 1 Per Share |
| 20 Sep 2023 | Dividend | Annual General Meeting/Dividend - Re 1 Per Share |
| 19 Sep 2022 | Dividend | Annual General Meeting/Dividend - Re 1 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.